CDT Equity Inc.
CDT CDTTWCIK 0001896212 · Pharmaceutical Preparations · Nasdaq, Nasdaq
- CONDUIT PHARMACEUTICALS INC. (until 2025-08-07)
- Murphy Canyon Acquisition Corp. (until 2023-09-21)
Revenue (TTM)
—
FY Apr 2026
Net Income (TTM)
−$24.36M
−120.3% YoY
FY Apr 2026
EPS Diluted (TTM)
−$909.42
+98.1% YoY
FY Apr 2026
Gross Margin
—
FY Apr 2026
Operating Margin
—
FY Apr 2026
Net Margin
—
FY Apr 2026
Free Cash Flow (TTM)
−$9M
FY Apr 2026
Cash
$1.51M
FY Apr 2026
Total Debt
—
FY Apr 2026
Shares Outstanding
4.86M sh
FY Apr 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.